Published in Gene Therapy Weekly, July 13th, 1998
K.M. Hege, representing colleagues from Cell Genesys, the University of California, and Stanford University, California, explained the process leading to the induction of clinical trials of a gene therapy designed around autologous T cells for colorectal cancer, at the 34th Annual Meeting of the American Society of Clinical Oncology, held May 16-19, 1998, in Los Angeles, California (abstract "T Cell Gene Therapy of Colorectal Cancer with Autologous CC49-Zeta Gene-Modified CD4 and CD8 T Cells").
"The antigen specificity of human T cells can be redirected...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.